Disposition and pharmacokinetics of a GalNAc3-Conjugated antisense oligonucleotide targeting human lipoprotein (a) in monkeys

被引：0
|
作者：
不详
机构：
来源：
CHIMICA OGGI-CHEMISTRY TODAY | 2018年 / 36卷 / 02期
关键词：
Oligonucleotide; phosphorothioate; oligonucleotide conjugate; antisense; GalNAc; lipoprotein; pharmacokinetics; ISIS; 681257;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [31] Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3
    Liu Chuan
    Wu Xiaohou
    Luo Chunli
    Hu Zili
    Yin Zhikang
    He Yunfeng
    Du Hu
    Zhang Weili
    Jiang Qing
    Lin Yanjun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29 : 63
  • [32] Antisense Oligonucleotide Targeting FUS-DDIT3 Oncogene for RNase H Degradation
    Hall, Erin F.
    Wentworth, Simon
    Gallagher, Jillian
    Taghian, Toloo
    Lopez, Yvette Diaz
    McElroy, Abigail W.
    Benatti, Hector Ribeiro
    Nath, Sarah
    Somaiah, Neeta
    D'Amato, Gina
    Watts, Jonathan K.
    Sena-Esteves, Miguel
    Gray-Edwards, Heather L.
    MOLECULAR THERAPY, 2024, 32 (04) : 367 - 367
  • [33] POPULATION PHARMACOKINETICS OF VOLANESORSEN, AN ANTISENSE OLIGONUCLEOTIDE TARGETING HUMAN APOLIPOPROTEIN C-III, IN HEALTHY SUBJECTS AND PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME OR HYPERTRIGLYCERIDEMIA.
    Hurh, E.
    Gunawan, R.
    Collins, J. W.
    Burroughs, E. G.
    Wang, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S70 - S70
  • [34] Cell-permeable peptide nucleic acid antisense oligonucleotide platform targeting human betacoronaviruses
    Park, Soree
    Kim, Seong Ho
    Dezhbord, Mehrangiz
    Lee, Eun-Hwi
    Jeon, Yeasel
    Jung, Daram
    Gu, Se Hun
    Yu, Chiho
    Lee, Seung Ho
    Kim, Sung Chun
    Kim, Kyun-Hwan
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [35] Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302)
    Watanabe, Tanya A.
    Geary, Richard S.
    Levin, Arthur A.
    OLIGONUCLEOTIDES, 2006, 16 (02) : 169 - 180
  • [36] Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide
    Gurlo, Tatyana
    Prakash, Thazha P.
    Wang, Zhongying
    Archang, Maani
    Pei, Lina
    Rosenberger, Madeline
    Pirie, Elaine
    Lee, Richard G.
    Butler, Peter C.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [37] GalNAc-Conjugated siRNA Targeting Complement C3 Inhibits Osteoclast Activation in Periodontitis
    Chen, Yingyi
    Liu, Yitong
    Fu, Zhongguo
    Xu, Junji
    Guo, Lijia
    Cao, Huiqing
    Gan, Liming
    Gao, Shan
    Liu, Yi
    ORAL DISEASES, 2024,
  • [38] Targeting ANGPTL3 by GalNAc-conjugated siRNA ANGsiR10 lowers blood lipids with long-lasting and potent efficacy in mice and monkeys
    Wang, Jue
    Zheng, Wen
    Zheng, Shuquan
    Yuan, Ye
    Wen, Wei
    Cui, Weiyi
    Xue, Lifang
    Sun, Xueting
    Shang, Haibao
    Zhang, Hongyan
    Xiao, Rui-Ping
    Gao, Shan
    Zhang, Xiuqin
    MOLECULAR THERAPY NUCLEIC ACIDS, 2023, 31 : 68 - 77
  • [39] Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis[S]
    Boffa, Michael B.
    Marar, Tanya T.
    Yeang, Calvin
    Viney, Nicholas J.
    Xia, Shuting
    Witztum, Joseph L.
    Koschinsky, Marlys L.
    Tsimikas, Sotirios
    JOURNAL OF LIPID RESEARCH, 2019, 60 (12) : 2082 - 2089
  • [40] Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of AZD2373, an antisense oligonucleotide targeting APOL1
    Greasley, Peter J.
    Agrawal, Nikhil
    Althage, Magnus
    Sanchez, Jose
    Kirk, Sarah
    Egeland, Erlend Johannessen
    Astrand, Magnus
    Westergren, Helena
    Sherwood, James
    Mccarthy, Michael
    Patel, Uptal
    Macphee, Iain
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
12345